普洛药业：完成1.50亿元股份回购，占总股本0.90%

Core Viewpoint - The company announced a share buyback plan, indicating a strategic move to enhance shareholder value and potentially support stock price stability [1] Summary by Relevant Sections Share Buyback Details - The company will repurchase a total of 10,442,300 shares from April 30 to November 12, 2025, which represents 0.90% of the current total share capital [1] - The maximum transaction price for the buyback is set at 15.59 yuan per share, while the minimum price is 13.62 yuan per share [1] - The total amount for the buyback is 150 million yuan, including transaction fees, funded by the company's own resources and loans from financial institutions [1] Compliance and Impact - The buyback plan complies with relevant regulations and does not have a significant impact on the company's overall operations or its listing status [1] - The repurchased shares are intended for employee stock ownership plans or equity incentives, with any unused shares within 36 months to be canceled [1]